Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Saudi J Biol Sci ; 28(1): 1093-1099, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33424404

RESUMO

Nanobiotechnology is a fast growing field in which instruments are created by nano size particles of approximately 1 to 100 nm (1 to 100 nm) of the scale of nanometers. Nanoparticles today have potential implications for life sciences and human health applications. In this research, silver nanoparticles (AgNPs) were successfully synthesized using Saussurea costus root aqueous extract and AgNPs have been characterized by the use of UV-Vis, Scanning Electron Microscopes (SEM), and Electromicroscopy of transmission (TEM) and Energy Dispersive X-ray Spectroscopy (EDXs). The highest number of particles are in the 5 to 15 nm range. AgNPs have been added in saffron dye solution for degradation dye biosynthesizing, and product analysis using UV/vision spectrophotometer, FTIR and HPLC has been performed. Green-summed AgNPs effectively degraded the color, with UV/VIS spectrophotometers, around 84.6 percent at 72 h of exposure time. The decrease in tested dye and presence of multiple new highs in the samples treated with different retention times (Rt) 2.30, 6.10 and 12.24 min, is positive for the biodegradation compared to the untreated dye with single high at 10.31 min, respectively. This green chemistry is very advantageous for AgNPs biosynthesis, for example, cost-effectiveness and usability for medicinal, pharmaceutical and extensive industrial applications. Furthermore, the bio-recovery unit for plant extracts provides a greater ease of handling, compared to micro-organisms.

2.
J Ethnopharmacol ; 199: 97-105, 2017 Mar 06.
Artigo em Inglês | MEDLINE | ID: mdl-28159725

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: The root of Saussurea costus (Aucklandia lappa Decne, Aucklandiae Radix, SC) and Thuja orientalis L. (TOL) have been traditionally used as anti-inflammatory agents in Korea. However, they have not been studied for the efficacy of atopic dermatitis (AD) treatment, a chronic inflammatory skin disease. We investigated the efficacy of topical applications with 1,3-butyleneglycol extracts of SC and TOL to alleviate the symptoms of AD. MATERIALS AND METHODS: HaCaT cells and the dorsal skin of Nc/Nga mice had a local exposure of house mite extracts and 2,4-dinitrochlorobenzene (DNCB), respectively. After lesions developed, we topically applied 1,3-butylen glycol (vehicle; control), SC (30%), TOL (30%), or SC (15%)+TOL (15%) to the skin lesions for 5 weeks. The normal-control was not exposed to DNCB. The skin thickness, mast cell infiltration, serum immunoglobulin E (IgE) and IgG1 and gene expressions of interleukin (IL)-4, IL-13, and IFN-γ in the dorsal skin and HaCaT cells were measured. RESULTS: Chlorogenic acid (129.6±10.2µg/g) for SC and catechin and apigenin (93.4±13.2 and 16.9±1.3µg/g, respectively) for TOL were used as indicator compounds for the strength of the extracts. SC+TOL decreased the expression of protease-activated receptor-2 and ICAM-1 and the release of TNF-α and IL-6 in HaCaT cells activated by 3µg/mL house mite extracts in comparison to either of SC or TOL alone. In Nc/Nga mice challenged with DNCB, SC+TOL synergistically attenuated clinical symptoms of AD such as erythema, hemorrhage, edema, excoriation and dryness in the dorsal skin better than either SC or TOL alone. Histological analysis of the dorsal skin also showed that SC+TOL treatment significantly and additively decreased the inflammatory cellular infiltrate, including mast cells and eosinophils in comparison to either of SC or TOL. SC+TOL also decreased serum IgE and IgG1 levels and the expression of IFN-γ, IL-4, and IL-13 mRNA in dorsal skin in DNCB-treated Nc/Nga mice. CONCLUSION: SC+TOL relieved the symptoms of AD by reducing pro-inflammatory activity and over-activated immune responses. These data suggest that SC+TOL may be an effective alternative intervention for the management of AD.


Assuntos
Dermatite Atópica/metabolismo , NF-kappa B/metabolismo , Extratos Vegetais/uso terapêutico , Receptor PAR-2/metabolismo , Saussurea , Thuja , Administração Tópica , Animais , Anti-Inflamatórios/isolamento & purificação , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/uso terapêutico , Linhagem Celular Transformada , Dermatite Atópica/tratamento farmacológico , Sinergismo Farmacológico , Humanos , Masculino , Camundongos , NF-kappa B/antagonistas & inibidores , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacologia , Distribuição Aleatória , Receptor PAR-2/antagonistas & inibidores , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA